vimarsana.com

Latest Breaking News On - Steven kirshblum - Page 1 : vimarsana.com

Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium ("2nd SCIIS"). The 2nd SCIIS aims.

Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)

Kessler Foundation receives $3M to expand neurotrauma research

Kessler Foundation awarded Social Security Administration funding to expand research for improving employment outcomes following neurotrauma

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.